Stay updated with breaking news from Respiratory Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysis of 60 and 90-day data from Phase 3 SPRINTER trial in hospitalised COVID-19 patients showed that SNG001 reduced risk of recognised Long COVID symptoms Company to present full analysis
For fatigue, the relative risk reduction was 35.4%, for shortness of breath 28.3% and for loss of smell and/or taste 61.4%
Investegate announcements from 4d Pharma PLC, 4D pharma to host virtual KOL event
As the Government cuts the COVID isolation period to 5 days, researchers warn that 1 in 3 people may still be infectious after the 5-day quarantine period.
Experts are of the view that Omicron might accelerate the transition of coronavirus from pandemic to endemic, as per media report.